EOLS Insider Trading
Insider Ownership Percentage: 6.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,359,057.01
Evolus Share Price & Price History
Current Price: $10.79
Price Change: ▲ Price Increase of +0.68 (6.73%)
As of 04/17/2025 05:00 PM ET
Evolus Insider Trading History
Evolus Institutional Trading History
Data available starting January 2016
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Read More on Evolus
Today's Range
Now: $10.79
52 Week Range
Now: $10.79
Volume
1,051,617 shs
Average Volume
658,837 shs
Market Capitalization
$686.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.97
Who are the company insiders with the largest holdings of Evolus?
Evolus' top insider investors include:
- Medytox Inc (Major Shareholder)
- David Moatazedi (Insider)
- Rui Avelar (Insider)
- Vikram Malik (Director)
- Sandra Beaver (CFO)
- Tomoko Yamagishi-Dressler (CMO)
- David N Gill (Director)
- Karah Herdman Parschauer (Director)
Learn More about top insider investors at Evolus.
Who are the major institutional investors of Evolus?
Which major investors are buying Evolus stock?
Within the previous quarter, EOLS stock was acquired by institutional investors including:
- Assenagon Asset Management S.A.
- GAMMA Investing LLC
- Rhumbline Advisers